1Hu OY, ftang HS, Chang CL. The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone-a novel galactose single point methld as a measure of residual liver function. Biopham Drug Dispos, 1994,15(7):563.
2Saudek f, Moravek J, Modr Z. Cefoperazone phamacokinetios in patinets with liver cirrhosis:a predictive value of the woviridin test.J Clin pharmacol Ther Toxicol, 1989,27(2):82.
